公司概覽
業務類別 Biotechnology
業務概覽 Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
公司地址 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
電話號碼 +1 857 259-3860
傳真號碼 +1 866 493-4935
公司網頁 https://www.scholarrock.com
員工數量 289
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Vikas Sinha Chief Financial Officer and Principal Accounting Officer 美元 523.08K 22/04/2026
Mr. David L. Hallal Chairman of the Board and Chief Executive Officer 美元 637.50K 22/04/2026
Mr. Robert Keith Woods Chief Operating Officer 美元 523.08K 22/04/2026
Mr. Mohammed Qatanani, PhD Chief Scientific Officer -- 22/04/2026
Dr. Jing L. Marantz, M.D.,PhD Chief Medical Officer -- 22/04/2026
Ms. Junlin Ho, J.D. General Counsel and Corporate Secretary -- 22/04/2026
Ms. Caryn Parlavecchio Chief Human Resources Officer -- 22/04/2026
Ms. Lisa Wyman Chief Technical and Quality Officer -- 22/04/2026
Ms. Rebecca McLeod Chief Brand Officer and U.S. General Manager -- 22/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Michael Gilman, PhD Independent Director 22/04/2026
Mr. David L. Hallal Chairman of the Board and Chief Executive Officer 22/04/2026
Ms. Kristina M. Burow Independent Director 22/04/2026
Ms. Katie Peng Independent Director 22/04/2026
 
所屬ETF (更新日期: 24/10/2026 04:15)
代號 名稱 佔比% ▼ 持有日期
ACSGAmerican Century Small Cp Gr Insgts ETF0.004%30/09/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.004%30/09/2026
SGRWHarbor Active Small Cap Growth ETF0.004%30/09/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.003%30/09/2026
BIBProShares Ultra Nasdaq Biotechnology0.003%30/09/2026
URTYProShares UltraPro Russell20000.003%30/09/2026
MSMLiShares MSCI USA Small-Cap ETF0.003%30/09/2026
STXKStrive Small-Cap ETF0.003%30/09/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.003%30/09/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%30/09/2026
TDNAT. Rowe Price Biotech ETF0.003%30/09/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.003%30/09/2026
BKSEBNY Mellon US Small Cap Core Equity ETF0.003%30/09/2026
UWMProShares Ultra Russell20000.003%30/09/2026
GRXGabelli Health & Wellness0.002%30/06/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%30/09/2026
ESSCEventide Small Cap ETF0.001%30/09/2026
FTKIFirst Trust Small Cp BuyWrt Inc ETF0.001%30/09/2026
PWSPacer WealthShield ETF0.001%30/09/2026
PCSGPolen 5Perspectives Small-Mid Growth ETF0.0005%30/09/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.